Suchergebnisse - "Lipka, Daniel B"

PubPharm (6)

1

The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13

enthalten in: Blood | 2021

von Zanetti, C. | Kumar, R. | Ender, J. | +22

CommentIn: Blood. 2021 Nov 11;138(19):1789-1790. - PMID 34762133

2

Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML

enthalten in: Blood | 2019

von Garg, S. | Reyes-Palomares, A. | He, L. | +20

CommentIn: Blood. 2019 Jul 18;134(3):222-224. - PMID 31320364

3

FLT3 as a therapeutic target in AML : still challenging after all these years

enthalten in: Blood | 2010

von Kindler, T. | Lipka, D. | Fischer, T.

4

FLT3 as a therapeutic target in AML: still challenging after all these years

enthalten in: Blood | 2010

von Kindler, T. | Lipka, D. | Fischer, T.

5

Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7

enthalten in: Blood | 2006

von Fröhling, S. | Lipka, D. | Kayser, S. | +6

6

Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain

enthalten in: Blood | 2006

von Heidel, F. | Solem, F. | Breitenbuecher, F. | +17

1
[1]